Michael Gillen
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Nephrology 22
- Gout, Hyperuricemia, Uric Acid 21
-
- Inhalation and Respiratory Drug Delivery 9
- Respiratory and Cough-Related Research 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Co-authors
- Zancong Shen (17 shared papers)Jesse Hall (11 shared papers)Philip Chaikin (4 shared papers)Jeffrey N. Miner (5 shared papers)Joel Morganroth (2 shared papers)David M. Wilson (9 shared papers)Bradley M. Kerr (6 shared papers)Sha Liu (5 shared papers)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Drug Design Development and Therapy (4 papers)British Journal of Clinical Pharmacology (4 papers)Clinical Therapeutics (4 papers)Pulmonary Pharmacology & Therapeutics (4 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Michael Gillen
55 papers receiving 677 citations
Peers
Comparison fields: 5 of 75
- Nephrology 247
- Pharmacology 83
- Immunology and Allergy 40
- Rheumatology 79
- Physiology 130
Countries citing papers authored by Michael Gillen
This map shows the geographic impact of Michael Gillen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gillen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gillen more than expected).
Fields of papers citing papers by Michael Gillen
This network shows the impact of papers produced by Michael Gillen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gillen. The network helps show where Michael Gillen may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Gillen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 37 | |
| 2 | 2016 | 37 | |
| 3 | 2017 | 34 | |
| 4 | 2005 | 32 | |
| 5 | 2018 | 30 | |
| 6 | 2001 | 28 | |
| 7 | 1999 | 27 | |
| 8 | 2016 | 24 | |
| 9 | 2010 | 23 | |
| 10 | 2016 | 23 | |
| 11 | 2001 | 21 | |
| 12 | 2008 | 20 | |
| 13 | 2017 | 19 | |
| 14 | 2010 | 19 | |
| 15 | 2008 | 18 | |
| 16 | 2018 | 16 | |
| 17 | 2018 | 16 | |
| 18 | 2017 | 15 | |
| 19 | 2016 | 15 | |
| 20 | 2015 | 15 |
About Michael Gillen
Michael Gillen is a scholar working on Nephrology, Pulmonary and Respiratory Medicine, Physiology, Surgery and Pharmacology, having authored 55 papers that have together received 698 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (21 papers), Inhalation and Respiratory Drug Delivery (9 papers), Asthma and respiratory diseases (8 papers), Case Reports on Hematomas (7 papers), Respiratory and Cough-Related Research (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Allergic Rhinitis and Sensitization (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Nephrology (247 citations), Pharmacology (83 citations), Immunology and Allergy (40 citations), Rheumatology (79 citations) and Physiology (130 citations). Michael Gillen has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Zancong Shen, Jesse Hall, Philip Chaikin, Jeffrey N. Miner, Joel Morganroth, David M. Wilson, Bradley M. Kerr, Sha Liu, David J. Roberts and Caroline Lee. Their work appears in journals such as The Journal of Clinical Pharmacology, Drug Design Development and Therapy, British Journal of Clinical Pharmacology, Clinical Therapeutics and Pulmonary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.